Literature DB >> 2939791

Action and toxicity of cyclosporine.

W M Bennett, D J Norman.   

Abstract

Cyclosporine is a potent new immunosuppressive agent that has proven particularly useful in organ transplantation. The unique action of the drug on T-cell immunity without myelosuppression is summarized. Cyclosporine pharmacology and adverse reactions, particularly nephrotoxicity, are reviewed in this paper.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2939791     DOI： 10.1146/annurev.me.37.020186.001243

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  28 in total

1.  Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.

Authors:  D H Van Thiel; M Iqbal; A Jain; J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Distribution of FK 506 in plasma lipoproteins in transplant patients.

Authors:  V Warty; R Venkataramanan; P Zendehrouh; T McKaveney; J Chao; S Todo; T Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

4.  A Peptidyl Inhibitor that Blocks Calcineurin-NFAT Interaction and Prevents Acute Lung Injury.

Authors:  Patrick G Dougherty; Manjula Karpurapu; Amritendu Koley; Jessica K Lukowski; Ziqing Qian; Teja Srinivas Nirujogi; Luiza Rusu; Sangwoon Chung; Amanda B Hummon; Hao W Li; John W Christman; Dehua Pei
Journal:  J Med Chem       Date:  2020-10-19       Impact factor: 7.446

Review 5.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

6.  Cyclosporine induces abnormal facial bone growth in children: a preliminary study.

Authors:  V M Reznik; J S Berger; K L Jones; S A Mendoza
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Cyclosporine-induced deterioration in patients with AIDS.

Authors:  A Phillips; M A Wainberg; R Coates; M Klein; A Rachlis; S Read; F Shepherd; H Vellend; S Walmsley; P Halloran
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

8.  Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  J Brodehl; M Brandis; U Helmchen; P F Hoyer; R Burghard; J H Ehrich; R B Zimmerhackl; W Klein; K Wonigeit
Journal:  Klin Wochenschr       Date:  1988-11-15

Review 9.  Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients.

Authors:  C Fiuza-Luces; R J Simpson; M Ramírez; A Lucia; N A Berger
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

10.  Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc.

Authors:  Yanhui Lu; Craig W Hendrix; Namandjé N Bumpus
Journal:  Drug Metab Dispos       Date:  2012-08-24       Impact factor: 3.922
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.